Skip to main content

Ry-Tann Side Effects

Generic name: chlorpheniramine / phenylephrine

Medically reviewed by Drugs.com. Last updated on May 7, 2024.

Note: This document provides detailed information about Ry-Tann Side Effects associated with chlorpheniramine / phenylephrine. Some dosage forms listed on this page may not apply specifically to the brand name Ry-Tann.

Applies to chlorpheniramine / phenylephrine: oral liquid, oral suspension extended release, oral tablet.

Important warnings This medicine can cause some serious health issues

Do not use this medicine if you have used an MAO inhibitor in the past 14 days, such as isocarboxazid, linezolid, methylene blue injection, phenelzine, rasagiline, selegiline, or tranylcypromine.

You should not use antihistamine medication to make a child sleepy.

Get emergency medical help if you have signs of an allergic reaction: hives; difficulty breathing; swelling of your face, lips, tongue, or throat.

Stop using this medicine and call your doctor at once if you have:

Common side effects may include:

This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects.

For healthcare professionals

Applies to chlorpheniramine/phenylephrine: oral capsule extended release, oral drops, oral elixir, oral liquid, oral suspension, oral suspension extended release, oral syrup, oral tablet, oral tablet chewable, oral tablet extended release.

Nervous system adverse events

Cardiovascular

Ocular

Genitourinary

Other

References

1. Sur DK, Plesa ML (2015) "Treatment of allergic rhinitis." Am Fam Physician, 92, p. 985-92

2. (1998) "PDR Generics." Montvale, NJ: Medical Economics

Further information

Ry-Tann side effects can vary depending on the individual. Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Note: Medication side effects may be underreported. If you are experiencing side effects that are not listed, submit a report to the FDA by following this guide.